First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging
Journal of Personalized Medicine · 30.06.2026 · 16 (7) · 358
DOI: 10.3390/jpm16070358 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 30.06.2026. Verfasst von Mariangela Pati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Obstetrics and Gynecologic Oncology, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Trisomy 21 (T21) is strongly associated with congenital heart disease, particularly atrioventricular septal defect (AVSD), ventricular septal defect (VSD), atrial septal defect (ASD) and selected conotruncal and arch anomalies. First- and second-trimester ultrasound, Doppler and fetal cardiac MRI enable increasingly early and detailed characterization of these lesions, while advances in molecular cardiogenesis have linked specific phenotypes to dosage-sensitive genes on chromosome 21.
Methods
This narrative review synthesizes contemporary evidence on structural and functional cardiovascular anomalies in T21 fetuses in the first and second trimester, integrating fetal echocardiography, Doppler assessment and fetal cardiac MRI with embryologic and molecular insights, and summarizing trimester-specific detectability and pathophysiologic links to candidate genes in the Down syndrome-critical region. Approximately one quarter to one third of T21 fetuses have major congenital heart disease on high-quality prenatal echocardiography, with AVSD representing about half of all lesions and VSD, tetralogy of Fallot (TOF), arch anomalies, venous return abnormalities and functional markers (increased nuchal translucency, tricuspid regurgitation, ductus venosus abnormalities) comprising the remainder.
Results
First-trimester detection relies on functional markers and early four-chamber and outflow-tract views, whereas second-trimester studies refine anatomic definition and hemodynamics, with MRI reserved for complex cases. Overexpression of genes such as DSCAM, COL6A1/COL6A2, DYRK1A and RCAN1 perturbs endocardial cushion, conotruncal and vascular development.
Conclusions
Early, protocol-driven cardiac imaging in T21 supports timely diagnosis, risk stratification and multidisciplinary counselling, and links fetal imaging phenotypes with chromosome 21 gene dosage to advance personalized management and future genotype–phenotype research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Obstetrics and Gynecologic Oncology, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.
- Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.
ORCID-Profile: Mariangela Pati, Immacolata Blasi, Lorenzo Aguzzoli, Maria Paola Bonasoni
Zitieren
APA
Pati, M., Blasi, I., Botticelli, G., Musarò, A., Vanacore, F., Galeati, G., Aguzzoli, L., & Bonasoni, M. P. (2026). First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging. Journal of Personalized Medicine, 16(7), 358. https://doi.org/10.3390/jpm16070358
Vancouver
Pati M, Blasi I, Botticelli G, Musarò A, Vanacore F, Galeati G, et al. First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging. Journal of Personalized Medicine. 2026;16(7):358. doi:10.3390/jpm16070358
BibTeX
@article{Pati2026,
author = {Pati, Mariangela and Blasi, Immacolata and Botticelli, Giovanna and Musarò, Andrea and Vanacore, Flavio and Galeati, Giulia and Aguzzoli, Lorenzo and Bonasoni, Maria Paola},
title = {First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {7},
pages = {358},
doi = {10.3390/jpm16070358}
}
EUVIMED